Corvus Pharmaceuticals, Inc.
Anti-CD73 antibodies
Last updated:
Abstract:
Provided herein are, inter alia, anti-CD73 antibodies and methods of using the same. The antibodies provided include amino acid substitution embodiments affecting the antibody glycosylation state. The antibodies provided herein are, inter alia, useful for the treatment of cancer and effective for inhibition of CD73 activity.
Status:
Grant
Type:
Utility
Filling date:
11 Jul 2017
Issue date:
6 Oct 2020